scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1196/ANNALS.1415.030 |
P698 | PubMed publication ID | 17567945 |
P2093 | author name string | Enrico Proietti | |
Filippo Belardelli | |||
Laura Bracci | |||
P2860 | cites work | The nature of the principal type 1 interferon-producing cells in human blood | Q29619763 |
Interferon-alpha in tumor immunity and immunotherapy | Q34568695 | ||
Leveraging the activity of tumor vaccines with cytotoxic chemotherapy | Q36258579 | ||
Type I interferons keep activated T cells alive | Q36367751 | ||
Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. | Q36368488 | ||
Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha | Q36371335 | ||
Type I interferon in systemic lupus erythematosus and other autoimmune diseases | Q36595839 | ||
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative | Q40591372 | ||
Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
Type I interferon-mediated stimulation of T cells by CpG DNA | Q41824775 | ||
The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol | Q43704400 | ||
IFN-alpha promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment | Q43948384 | ||
Prognostic significance of autoimmunity during treatment of melanoma with interferon. | Q44019499 | ||
Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. | Q44550766 | ||
Induction of bystander T cell proliferation by viruses and type I interferon in vivo | Q46486509 | ||
International meeting on cancer vaccines: how can we enhance efficacy of therapeutic vaccines? | Q53284971 | ||
Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. | Q53718320 | ||
Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon | Q57275922 | ||
Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-α | Q57791171 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 256-268 | |
P577 | publication date | 2007-06-13 | |
P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
P1476 | title | IFN-alpha and novel strategies of combination therapy for cancer | |
P478 | volume | 1112 |
Q39609067 | Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation |
Q90419584 | Current Perspectives in Cancer Immunotherapy |
Q41901253 | GK-1 improves the immune response induced by bone marrow dendritic cells loaded with MAGE-AX in mice with melanoma. |
Q41958567 | IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases |
Q34204603 | PKC-δ mediates interferon-α-induced apoptosis through c-Jun NH₂-terminal kinase activation |
Q57159202 | Perspectives on interferon-alpha in the treatment of Polycythemia vera and related Myeloproliferative neoplasms: minimal residual disease and cure? |